Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates.

Antimicrobial Agents and Chemotherapy
John QualeDavid Landman

Abstract

Carbapenems are important agents for the therapy of infections due to multidrug-resistant Pseudomonas aeruginosa; the development of carbapenem resistance hampers effective therapeutic options. To assess the mechanisms leading to resistance, 33 clinical isolates with differing degrees of carbapenem susceptibility were analyzed for the expression of the chromosomal beta-lactamase (ampC), the porin that is important for the entry of carbapenems (oprD), and the proteins involved in four efflux systems (mexA, mexC, mexE, and mexX). Real-time reverse transcriptase PCR was performed using primers and fluorescent probes for each of the target genes. The sequencing of regulatory genes (ampR, mexR, nalC, nalD, mexT, and mexZ) was also performed. Diminished expression of oprD was present in all imipenem- and meropenem-resistant isolates but was not required for ertapenem resistance. Increased expression of ampC was not observed in several isolates that were overtly resistant to carbapenems. Increased expression of several efflux systems was observed in many of the carbapenem-resistant isolates. Increased efflux activity correlated with high-level ertapenem resistance and reduced susceptibility to meropenem and aztreonam. Most isolates wi...Continue Reading

References

Jul 1, 1988·Reviews of Infectious Diseases·R E Hancock, W A Woodruff
Apr 28, 1997·Biochemical and Biophysical Research Communications·H YoneyamaT Nakae
Jan 30, 1999·Antimicrobial Agents and Chemotherapy·T MineT Tsuchiya
Jan 30, 1999·Antimicrobial Agents and Chemotherapy·T KöhlerJ C Pechere
Aug 22, 2000·Antimicrobial Agents and Chemotherapy·N MasudaT Nishino
Nov 18, 2000·Antimicrobial Agents and Chemotherapy·N MasudaT Nishino
Feb 13, 2001·Antimicrobial Agents and Chemotherapy·H PaiN Gotoh
Feb 27, 2001·The Journal of Antimicrobial Chemotherapy·D M Livermore
Feb 2, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David M Livermore
Jun 27, 2002·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·P Nordmann, L Poirel
Jan 22, 2003·Environmental Microbiology·Jean-Paul PirnayMartin Zizi
May 23, 2003·Antimicrobial Agents and Chemotherapy·Didier HocquetPatrick Plésiat
Jul 12, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John QualeRenuka Heddurshetti
Apr 24, 2004·Antimicrobial Agents and Chemotherapy·Catherine LlanesPatrick Plésiat
Sep 24, 2004·Diagnostic Microbiology and Infectious Disease·Daniel J WolterPhilip D Lister
Dec 14, 2004·The Journal of Antimicrobial Chemotherapy·Claire HéritierPatrice Nordmann
Feb 12, 2005·The Journal of Antimicrobial Chemotherapy·David M LivermoreMarina Warner

❮ Previous
Next ❯

Citations

Jun 9, 2009·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·L VettorettiX Bertrand
Jan 26, 2010·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S A DunhamA A Miller
Feb 20, 2009·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Jian-Fang ZhangZhi-Kai Xu
May 13, 2009·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Owe KällmanBarbro Olsson-Liljequist
Jul 30, 2011·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Maria Rosalia PascaPiero Marone
Mar 30, 2012·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Lorena C C FehlbergAna C Gales
Apr 17, 2013·The Journal of Antimicrobial Chemotherapy·Damien FournierKaty Jeannot
Dec 6, 2008·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Philip ToltzisJeffrey Blumer
Jan 10, 2009·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·David J MarquardtCheryl L Sargel
May 13, 2009·Antimicrobial Agents and Chemotherapy·Ellen Z BaumKaren Bush
Sep 10, 2008·Antimicrobial Agents and Chemotherapy·Amber J Schmidtke, Nancy D Hanson
Jul 27, 2011·Antimicrobial Agents and Chemotherapy·Farid El GarchYouri Glupczynski
Sep 10, 2009·Antimicrobial Agents and Chemotherapy·José-Manuel Rodríguez-MartínezPatrice Nordmann
Nov 26, 2009·Antimicrobial Agents and Chemotherapy·Carlos JuanUNKNOWN Spanish Network for Research in Infectious Diseases
Dec 10, 2009·Antimicrobial Agents and Chemotherapy·Karen Bush, George A Jacoby
Oct 10, 2012·Antimicrobial Agents and Chemotherapy·Gabriel CabotUNKNOWN Spanish Network for Research in Infectious Diseases (REIPI)
Mar 5, 2009·Antimicrobial Agents and Chemotherapy·José-Manuel Rodríguez-MartínezPatrice Nordmann
Mar 2, 2011·Antimicrobial Agents and Chemotherapy·Gabriel CabotUNKNOWN Spanish Network for Research in Infectious Diseases (REIPI)
Mar 2, 2011·Antimicrobial Agents and Chemotherapy·Laura ZamoranoAntonio Oliver
Feb 1, 2012·Antimicrobial Agents and Chemotherapy·Alain A Ocampo-SosaUNKNOWN Spanish Network for Research in Infectious Diseases (REIPI)
Jan 5, 2012·Antimicrobial Agents and Chemotherapy·Premavathy LevasseurChristine Miossec
Jul 17, 2007·Clinical Microbiology Reviews·Anne Marie Queenan, Karen Bush
Jan 13, 2009·Clinical Microbiology Reviews·George A Jacoby
Jan 25, 2012·PLoS Biology·Elif ErenBert van den Berg
Mar 25, 2008·Therapeutics and Clinical Risk Management·Douglas N Fish
Aug 15, 2009·Drugs·Xian-Zhi Li, Hiroshi Nikaido

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.